SeconDary Stroke PreVEntion ThRough Pathway ManagemenT (DiVERT Stroke)
Stroke
Current intervention as of 29/12/2021: The DiVERT Stroke Phase I Clinical Study is a retrospective data collection study investigating hospital admissions of cryptogenic stroke, large artery atherosclerosis, and small vessel occlusion patients and the related care pathway. De-identified patient-level data, as outlined below, will be extracted from medical records and hospital cost/charge accounting. This data will be linked with patient-level data from the AHA® Get with the Guidelines® (GWTG) hospital-based quality improvement program to provide a longitudinal view of each patient’s care, outcomes and costs. Additionally, sites will provide Medtronic with documentation of their current stroke care pathways, standard order sets, and other protocols related to stroke patient care. _____ Previous intervention as of 20/05/2021: The DiVERT Stroke Phase I Clinical Study is a retrospective study with a specific focus on collecting data around the stroke and related care pathway. De-identified patient-level data, as outlined below, will be extracted from medical records and hospital cost/charge accounting. This data will be linked with patient-level data from the AHA® Get with the Guidelines® (GWTG) hospital-based quality improvement program to provide a longitudinal view of each patient’s care, outcomes and costs. Additionally, sites will provide Medtronic with documentation of their current stroke care pathways, standard order sets, and other protocols related to stroke patient care. _____ Previous intervention: The DiVERT Stroke Phase I Clinical Study is a retrospective study with a specific focus on collecting data around the cryptogenic stroke and related care pathway. De-identified patient-level data, as outlined below, will be extracted from medical records and hospital cost/charge accounting. This data will be linked with patient-level data from the AHA® Get with the Guidelines® (GWTG) hospital-based quality improvement program to provide a longitudinal view of
Current inclusion criteria as of 01/09/2022: US Inclusion Criteria: 1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2017 – 2019 2. Age ≥18 years UK Inclusion Criteria: 1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2019-2020. If ischemic stroke sub-type classification proves to be difficult (i.e., small sample size), patients with an ischemic stroke from 2017-2019 will be included. 2. Age ≥18 years Previous inclusion criteria from 20/05/2021 to 01/09/2022: 1. Patients with a cryptogenic stroke or large artery atherosclerosis or small vessel occlusion hospitalization between 2017 – 2019 2. Age ≥18 years Previous inclusion criteria: 1. Patients with a cryptogenic stroke hospitalization defined by ICD-10 I63.9 between 2017 – 2019 2. Age ≥18 years
Current exclusion criteria as of 20/05/2021: Does not meet inclusion criteria Previous exclusion criteria: 1. Any history of the following through index stroke: 1.1. Lacunar stroke 1.2. Large artery atherosclerosis 1.3. Diagnosis of AF or atrial flutter 1.4. Ablation for AF or atrial flutter 1.5. OAC use 1.6. Methamphetamines drug use 1.7. Mechanical heart valves 1.8. Rheumatic heart disease 1.9. Mitral stenosis 1.10. Ischemic cardiomyopathy 1.11. Dilated cardiomyopathy 1.12. ST-elevation MI 1.13. Vasculitis 1.14. End stage renal disease 1.15. ICM implant prior to index event 2. VT Ablation within 30 days of index event 3. Non-AF left atrial or ventricular ablation within 30 days of index event 4. Any of the following within 30 days pre to 90 days post index stroke: 4.1. Carotid artery stenting 4.2. Carotid endarterectomy 4.3. Carotid artery stenosis or occlusion 4.4. ASD closure device insertion